137 related articles for article (PubMed ID: 17229524)
21. BDNF polymorphism associates with decline in set shifting in Parkinson's disease.
van der Kolk NM; Speelman AD; van Nimwegen M; Kessels RP; IntHout J; Hakobjan M; Munneke M; Bloem BR; van de Warrenburg BP
Neurobiol Aging; 2015 Mar; 36(3):1605.e1-6. PubMed ID: 25444596
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
Ross OA; Wu YR; Lee MC; Funayama M; Chen ML; Soto AI; Mata IF; Lee-Chen GJ; Chen CM; Tang M; Zhao Y; Hattori N; Farrer MJ; Tan EK; Wu RM
Ann Neurol; 2008 Jul; 64(1):88-92. PubMed ID: 18412265
[TBL] [Abstract][Full Text] [Related]
23. The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder.
Monteleone P; Zanardini R; Tortorella A; Gennarelli M; Castaldo E; Canestrelli B; Maj M
Neurosci Lett; 2006 Oct; 406(1-2):133-7. PubMed ID: 16901635
[TBL] [Abstract][Full Text] [Related]
24. CARD15 variants in patients with sporadic Parkinson's disease.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Juzwiak S; Kurzawski G; Tan EK; Drozdzik M
Neurosci Res; 2007 Mar; 57(3):473-6. PubMed ID: 17174426
[TBL] [Abstract][Full Text] [Related]
25. Association of BDNF Val66MET Polymorphism With Parkinson's Disease and Depression and Anxiety Symptoms.
Cagni FC; Campêlo CLDC; Coimbra DG; Barbosa MR; Júnior LGO; Neto ABS; Ribeiro AM; Júnior COG; Gomes de Andrade T; Silva RH
J Neuropsychiatry Clin Neurosci; 2017; 29(2):142-147. PubMed ID: 27852165
[TBL] [Abstract][Full Text] [Related]
26. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
Bian JT; Zhang JW; Zhang ZX; Zhao HL
Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
[TBL] [Abstract][Full Text] [Related]
27. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
28. Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohort.
Tedde A; Putignano AL; Nacmias B; Bagnoli S; Cellini E; Sorbi S
Neurosci Lett; 2008 Dec; 446(2-3):139-42. PubMed ID: 18834925
[TBL] [Abstract][Full Text] [Related]
29. Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.
Refenes N; Bolbrinker J; Tagaris G; Orlacchio A; Drakoulis N; Kreutz R
BMC Neurol; 2009 Jun; 9():26. PubMed ID: 19558713
[TBL] [Abstract][Full Text] [Related]
30. Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
Wu Y; Zhang Y; Han X; Li X; Xue L; Xie A
Neurol Sci; 2016 Dec; 37(12):1923-1929. PubMed ID: 27481110
[TBL] [Abstract][Full Text] [Related]
31. The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population.
Tsai SJ; Hong CJ; Liu HC; Liu TY; Liou YJ
Dement Geriatr Cogn Disord; 2006; 21(3):139-43. PubMed ID: 16391475
[TBL] [Abstract][Full Text] [Related]
32. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
[TBL] [Abstract][Full Text] [Related]
33. Is the G2019S LRRK2 mutation common in all southern European populations?
Papapetropoulos S; Adi N; Shehadeh L; Bishopric N; Singer C; Argyriou AA; Chroni E
J Clin Neurosci; 2008 Sep; 15(9):1027-30. PubMed ID: 18617409
[TBL] [Abstract][Full Text] [Related]
34. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
Tobin JE; Latourelle JC; Lew MF; Klein C; Suchowersky O; Shill HA; Golbe LI; Mark MH; Growdon JH; Wooten GF; Racette BA; Perlmutter JS; Watts R; Guttman M; Baker KB; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Laramie JM; DeStefano AL; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Sherman S; Al-hinti J; Drasby E; Nance M; Moller AT; Ostergaard K; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
Neurology; 2008 Jul; 71(1):28-34. PubMed ID: 18509094
[TBL] [Abstract][Full Text] [Related]
35. Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients.
Nishimura AL; Oliveira JR; Mitne-Neto M; Guindalini C; Nitrini R; Bahia VS; de Brito-Marques PR; Otto PA; Zatz M
J Mol Neurosci; 2004; 22(3):257-60. PubMed ID: 14997020
[TBL] [Abstract][Full Text] [Related]
36. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset.
Hong CJ; Liu HC; Liu TY; Lin CH; Cheng CY; Tsai SJ
Neurosci Lett; 2003 Dec; 353(1):75-7. PubMed ID: 14642442
[TBL] [Abstract][Full Text] [Related]
37. Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression.
Desai P; Nebes R; DeKosky ST; Kamboh MI
Neurosci Lett; 2005 May; 379(3):229-34. PubMed ID: 15843069
[TBL] [Abstract][Full Text] [Related]
38. Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism.
Jacob S; Brune CW; Carter CS; Leventhal BL; Lord C; Cook EH
Neurosci Lett; 2007 Apr; 417(1):6-9. PubMed ID: 17383819
[TBL] [Abstract][Full Text] [Related]
39. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
[TBL] [Abstract][Full Text] [Related]
40. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
